“SCENESSE®: Commercialization of a First-In-Class NCE”

In Clinical Development, Featured on App, Market Access, Orphan Drug Congress by Freya SmaleLeave a Comment

Nicoletta Muner of Clinuvel Pharmaceuticals Ltd.   joined us for World Orphan Drug Congress USA 2015 to present about ‘ SCENESSE®    :Commercialization of a First-In-Class NCE’ 
Download her presentation now to understand more about:

  • Scenesse Clincial Program
  • Erythropoietic Protoporphyria (EPP)
  • EPP Clinical Development and Expanded Access
  • EMA Evaluation (Centralised Procedur)
…and much more!
Get your copy here!
To find out more about  SCENESSE®   , attend  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.

Leave a Comment